Oral alprazolam acutely increases nucleus accumbens perfusion.
Oral alprazolam acutely increases nucleus accumbens perfusion.
复制标题
口服阿普唑仑可急剧增加伏隔核灌注。
DOI:
10.1038/mp.2012.139
复制
发表时间:
2013
影响因子:
11
通讯作者:
Gur,RE
中科院分区:
文献类型:
--
作者:
Wolf,DH;Pinkham,AE;Satterthwaite,TD;Ruparel,K;Elliott,MA;Valdez,J;Smith,MA;Detre,JA;Gur,RC;Gur,RE
Benzodiazepines treat anxiety, but can also produce euphoric effects, contributing to abuse. Using perfusion magnetic resonance imaging, we provide the first direct evidence in humans that alprazolam (Xanax) acutely increases perfusion in the nucleus accumbens, a key reward-processing region linked to addiction. Benzodiazepines exert not only therapeutic anxiolytic effects but also undesirable side effects by enhancing GABA signaling through receptors expressed widely in the brain. Benzodiazepine receptors are enriched in human ventral striatum/nucleus accumbens, 1 a critical region for normal and pathological motivational processes. Recent non-human studies demonstrated that benzodiazepines activate accumbens through alpha-1 GABA receptor-mediated disinhibition of mesolimbic dopamine projections to accumbens, 2 as well as through direct effects on alpha-2 GABA receptors. 3 However, there is no direct evidence of benzodiazepine effects on accumbens in humans. Pharmacological effects on regional brain function are coupled to changes in regional cerebral blood flow (CBF) and can be detected using arterial spin labeled (ASL) perfusion MRI. We used pulsed ASL (PASL) with previously described acquisition and analysis methods4 to examine the effects of oral alprazolam (1 mg) administered 1h before MRI in a balanced crossover placebocontrolled double-blind design (see Wolf et al. 5 for details of study procedures, sample and fMRI results; PASL was performed before fMRI). All procedures were performed with written informed consent and Penn Institutional Review Board approval. Usable PASL data were obtained from 45 of 47 healthy adult subjects including 19 unaffected relatives of patients with schizophrenia. As alprazolam-induced perfusion changes did not differ by family history, subjects were pooled in a combined analysis. To localize the effects of alprazolam on regional brain function, we examined relative CBF changes, normalized by whole brain mean CBF. 6 Alprazolam did not significantly change global CBF, 5 and absolute regional CBF results were qualitatively similar to these normalized results.A single dose of oral alprazolam increased CBF in accumbens (Figure 1), compared with placebo. Furthermore, subjects with higher accumbens perfusion on alprazolam showed faster (r¼ À 0.35, P¼ 0.020) and less accurate (r¼ À 0.30, P¼ 0.045) responses in a memory task following the perfusion scan. 5 In contrast, CBF was reduced in a cluster spanning posterior thalamus and posterior midbrain. Subjects with lower thalamus perfusion after alprazolam had slower reaction times (r¼ À 0.31, P¼ 0.040) with no relationship to accuracy (r¼ 0.004, P¼ 0.98). Drug effects in accumbens and thalamus/midbrain were not correlated (r¼ 0.12, P¼ 0.43), suggesting they may reflect different aspects of drug action. These results provide the first direct demonstration in humans of selective benzodiazepine effects on accumbens, consistent with GABAergic activation of the mesolimbic dopamine system. However, identifying the precise neuronal source of this effect requires further investigation (see Supplementary discussion). Anxiolytic effects of benzodiazepines have been linked to reduced amygdala activity. We suggest that increased accumbens perfusion reflects known effects of benzodiazepines including euphoria, disinhibition, impulsivity, risk-taking and addiction. The observed relationship between greater alprazolam-induced accumbens resting perfusion and more impulsive responding in a subsequent cognitive task supports this interpretation. Alprazolam may also have antidepressant effects, 7 and may produce …